Antares pharma announces oral presentation at the 22nd annual fall scientific meeting of smsna

Ewing, n.j., oct. 25, 2021 (globe newswire) -- antares pharma, inc. (nasdaq: atrs) (the “company”), a specialty pharmaceutical company, today announced that an abstract on xyosted®, a subcutaneous testosterone enanthate injection, was accepted as on oral presentation at the 22nd annual fall scientific meeting of smsna in scottsdale, az on october 21-24, 2021.
ATRS Ratings Summary
ATRS Quant Ranking